Displaying 1 - 12 of 13
Liver Tumours
6

AstraZeneca: Evolution Of HCC Management: Clinical Considerations For Mdt-Directed Care And Treatment Selection - EASL Liver Cancer Summit 2024

View
Liver Tumours
6

AstraZeneca: Evolution Of HCC Management: Clinical Considerations For Mdt-Directed Care And Treatment Selection - EASL Liver Cancer Summit 2024

View
Liver Tumours
6

AstraZeneca: Evolution Of HCC Management: Clinical Considerations For Mdt-Directed Care And Treatment Selection - EASL Liver Cancer Summit 2024

View
Liver Tumours
6

AstraZeneca: Evolution Of HCC Management: Clinical Considerations For Mdt-Directed Care And Treatment Selection - EASL Liver Cancer Summit 2024

View
Liver Tumours
6

AstraZeneca: Evolution Of HCC Management: Clinical Considerations For Mdt-Directed Care And Treatment Selection - EASL Liver Cancer Summit 2024

View
Liver Tumours
6

AstraZeneca: Evolution Of HCC Management: Clinical Considerations For Mdt-Directed Care And Treatment Selection - EASL Liver Cancer Summit 2024

View
General Hepatology
7

E-Scopics: “Innovations in point-of-care ultrasound for the management of NAFLD-NASH: seeing is believing” - EASL Congress 2023

View
General Hepatology
7

E-Scopics: “Innovations in point-of-care ultrasound for the management of NAFLD-NASH: seeing is believing” - EASL Congress 2023

View
General Hepatology
7

E-Scopics: “Innovations in point-of-care ultrasound for the management of NAFLD-NASH: seeing is believing” - EASL Congress 2023

View
General Hepatology
7

E-Scopics: “Innovations in point-of-care ultrasound for the management of NAFLD-NASH: seeing is believing” - EASL Congress 2023

View
General Hepatology
7

E-Scopics: “Innovations in point-of-care ultrasound for the management of NAFLD-NASH: seeing is believing” - EASL Congress 2023

View
General Hepatology
7

E-Scopics: “Innovations in point-of-care ultrasound for the management of NAFLD-NASH: seeing is believing” - EASL Congress 2023

View
Displaying 1 - 12 of 13